Oxford Advanced Surfaces Lists on AIM
Oxford Advanced Surfaces (“OAS”), a spin-out company of the University of Oxford, has listed on the Alternative Investment Market (AIM), and has achieved a market capitalisation of £84.5 million
We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
Oxford Advanced Surfaces (“OAS”), a spin-out company of the University of Oxford, has listed on the Alternative Investment Market (AIM), and has achieved a market capitalisation of £84.5 million
The ordinary shares of Oxford Advanced Surfaces Group (OASG) have been admitted to trading on AIM with the ticker symbol OXA following the completion of a reverse takeover of Kanyon Plc.
In 1998 Isis issued a licence to Mabtech AB, Stockholm, Sweden, for development and marketing of an enzyme-linked immunospot (ELISpot) assay technique capable of detecting peptide-specific effector T cells.
Scientists at Oxford University have released the latest version of their FSL software, which allows clinicians and researchers to analyse images of the brain, providing insights and improved treatment of conditions including schizophrenia, Alzheimer’s disease, multiple sclerosis, epilepsy, and Parkinson’s.
Technology used widely in Japan to keep buildings and streets spotless is now available in Europe and is expected to find wide applications in new construction materials and road furniture.
In a major move to exploit its innovative location monitoring technology, OxLoc Ltd, an Oxford University spin-out company, has chosen to partner with the leading European animal tracking company Televilt.
Rockstar Games confirmed in June 2007 that it is using euphoria technology from NaturalMotion Ltd in the computer game Grand Theft Auto IV, due for release in late 2007. The Grand Theft Auto franchise is one of the best-selling of all games titles.
The OxLoc asset alert, a self contained, long life, battery powered GPS/GSM tracking device has been used by one of OxLoc’s customers to successfully recover two vehicles stolen from his fleet.
In June 2007 Oxford University spun out a new company called Clinox from the Department of Clinical Pharmacology. Clinox offers pharmaceutical and biotechnology companies knowledge and expertise in the development, placement and conduct of early phase clinical trials with a particular focus in oncology.
Over 100 representatives from the business, technology, research and investment communities in Oxfordshire and beyond gathered at the Said Business School last night as the winners of the Martin and Audrey Wood Enterprise Awards 2007 were chosen.